Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin Dose-Response fMRI Study
NCT06144255Phase 1Completed
- Start
- Nov 2023
- Primary completion
- Feb 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of regular human insulin in traumatic brain injury (TBI). Primary endpoint: Change in Signal response using fMRI after administration of intranasal insulin. Started Nov 2023; status: completed.
02
Drugs
regular human insulin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06144255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06144255.